Neutralization of Japanese Encephalitis Virus by heme-induced broadly reactive human monoclonal antibody

Nimesh Gupta1,2,3, Mélissanne de Wispelaere4, Maxime Lecerf1,2,3

  • 1INSERM, UMR S 1138, Centre de Recherche des Cordeliers, Paris, France.

Scientific Reports
|November 7, 2015
PubMed

Geographical expansion and re-emerging new genotypes of the Japanese encephalitis virus (JEV) require the development of novel therapeutic approaches. Here, we studied a non-conventional approach for antibody therapy and show that, upon exposure to heme, a fraction of natural human immunoglobulins acquires high-affinity reactivity with the antigenic domain-III of JEV E glycoprotein. These JEV-reactive antibodies exhibited neutralizing activity against recently dominant JEV genotypes. This study opens new therapeutic options for Japanese encephalitis.